Alnylam Pharmaceuticals
ALNY
ALNY
398 hedge funds and large institutions have $19B invested in Alnylam Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 139 increasing their positions, 131 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
398
Holders Change
+10
Holders Change %
+2.58%
% of All Funds
6.95%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.16%
New
55
Increased
139
Reduced
131
Closed
44
Calls
$269M
Puts
$253M
Net Calls
+$16.1M
Net Calls Change
-$13.4M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
$918M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
$170M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
$160M |
| 4 |
Holocene Advisors
New York
|
$94.1M |
| 5 |
JPMorgan Chase & Co
New York
|
$439M |
Top Sellers
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
$49.6M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$20.3M |
| 3 |
BlackRock
New York
|
$1.47B |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
$33.1M |
| 5 |
Invesco
Atlanta,
Georgia
|
$170M |
